Dementia, Mild Cognitive Impairment, Normal elderly, Lewy body dementia, Cerebrovascular disease, Cerebral infarction, Cerebral contusion, Cerebral hemorrhage, Aftereffect of cerebral hemorrhage, Basilar artery occlusion, Cerebral arteriosclerosis, Multiple cerebral infarction, Cerebral atrophy, Vascular dementia, Chronic subdural hematoma, Parkinson'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: No dementia. No heart disease, no respiratory disease. No exercised more than an hour per week. Continue to participate in the experiment for three months. Those families and staff who can cooperate on confirmation of exercises. After enough explanation of the trial, those who agree with participation and give written informed consent.
Exclusion criteria
Exclusion criteria: Patients who are judged by the collaborative research investigator (psychiatrist). Heart disease, respiratory disease. Blind, full deafness. No families or carers. Regular exercise or training at least once a week.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The screening instrument for the detection of mild cognitive impairment is compared before and after intervention for three months. | — |
Secondary
| Measure | Time frame |
|---|---|
| The evaluation of the swallowing function effect is measured with a tongue pressure gauge and a spirometer. In addition, evaluating the motor function improvement effect is autonomic nerve function measurement, another improvement effect is to evaluate QOL and investigate the activity. | — |
Countries
Japan
Contacts
RIKEN Research Cluster for Innovation, Nakamura Laboratory